We sought to establish the mechanism for the raised serum estrogen levels that occur in male rats with portal hypertension and resultant portal bypass. Using the portal vein ligated (PVL) rat model, we evaluated plasma steroid hormone concentrations, metabolic clearance rate (MCR) of estradiol, and hepatic metabolism of androstenedione to estrogens and other products. In contrast to serum testosterone levels that were reduced, serum androstenedione levels were normal in the PVL rat. Estradiol MCR was measured by a constant intravenous infusion technique and was found to be similar in PVL and control animals. Androstenedione MCR was determined during constant intravenous infusion of [Hjandrostenedione, and the resultant radiolabeled steroids present in plasma were separated by thin layer chromatography. The MCR of androstenedione was not diminished in PVL rats compared with controls. However, there was a sevenfold increase in the plasma estradiol derived from I3Hlandrostenedione in rats with portal bypass. Examination of radiolabel excreted in bile during infusion of [3Hlandrostenedione showed that 25-46% of this steroid was converted to estradiol in PVL rats compared with < 3% in control male rats (P < 0.001). Moreover, there was a selective reduction in the excretion of 16a-hydroxyandrostenedione, a finding which suggested that the metabolism of androstenedione via this pathway was decreased. Androstenedione 16a-hydroxylation is known to be catalyzed by a malespecific cytochrome P450 isoform, P45OUT-A We conclude that raised plasma estradiol levels after portal bypass in male rats are due to increased production rates, resulting in turn from enhanced aromatization of androstenedione to estradiol. On the basis of the observed specific changes in androstenedione hydroxylation pathways, it is proposed that alterations in levels of sex-specific forms of cytochrome P450 occur in male rats with portal bypass and could account for the enhanced formation of estradiol.
Introduction
Portal bypass is a pathophysiologic state in which splanchnic blood is diverted from the liver to enter the systemic circulation directly. It may occur due to surgical creation of a portacaval shunt or because of an obstruction to flow through the portal venous system leading to portal hypertension and the resultant development of portasystemic venous anastomoses. The latter situation occurs in cirrhotic liver disease (1, 2) and can also be produced experimentally by occlusions of the portal vein (3, 4). Irrespective of its cause, portal bypass is associated with liver atrophy and a variety of metabolic changes (3-7). One such change is a reduced level of hepatic microsomal cytochrome P-450, a key component of mixed function oxidase enzymes concerned with the metabolism of foreign compounds and of steroid hormones (4, 5, 8-10).
Recent investigations have established that reduced hepatic mixed-function oxidase activity after portal bypass occurs only in intact male rats; reduced activity was not apparent in microsomes from castrated male or from female rats subjected to portal bypass (10, 1 1). Moreover, the lowering of mixed function oxidase activities was confined to those enzymes that display a striking sex dependence, being severalfold more active in male than in female rat liver microsomes (1 1, 12). Using a simple rat model of portal bypass, the portal vein ligated (PVL)' rat, it was also observed that changes in drug metabolising enzymes were associated with testicular atrophy (1 1). Serum testosterone concentrations were decreased concomitantly in this and in other models of portal bypass in rats (10, 11, 13). Levels of serum luteinizing hormone were also reduced in these animals (1 1, 13), a finding that is consistent with altered hypothalamic-pituitary regulation of sex hormone metabolism.
Hyperestrogenism and feminization are prominent clinical features in humans with chronic liver disease (14-17). It is therefore of considerable interest that the changes in testicular size and function in PVL male rats have been associated with raised estrogen levels in blood and in urine (1 1). In males, estrogen usually arises from the testes and the adrenals either by direct secretion or after "peripheral" conversion of androgenic precursors. This conversion occurs by aromatization of the steroid A ring of androgens (18, 19) . Although the peripheral site(s) of androgen aromatization to estrogens is unclear (20) (21) (22) (23) (24) , note that this process appears to be accelerated in men with chronic liver disease (25) .
The present studies were undertaken to determine the source of raised serum estrogen levels in PVL rats as it seemed possible that portal bypass may be partially responsible for changes in sex steroid metabolism in chronic liver disease (1 1, 13). In PVL male rats, experiments were designed (i) to elucidate the role of the testes as a source of raised serum estrogen concentrations, (ii) to determine whether estradiol clearance was impaired, and (iii) to examine the disposition and metabolism of androstenedione. (26) except that column chromatography (27) was used to separate estrone and estradiol in plasma samples. Ethylene glycol was used as the stationary phase and the estrone fraction was eluted with 15% ethylacetate in isooctane. The sensitivity of the estrogen assays was 1 pg/ml. The coefficient of variation for the estrone assay was 6.9% (at 20 pg/ml) and for estradiol, 13% (at 10 pg/ml). Cross-reactivity of the estradiol antiserum with estrone was 1.4% and of the estrone antiserum with estradiol, 5.8%.
Methods
Androstenedione. Androstenedione was determined by radioimmunoassay using a method based on that of Coyotupa et al. (28) .
[3H]Androstenedione was added to the plasma before extraction, to correct for losses, and results were adjusted for extraction efficiency (74±4.7%, mean±SD, n = 42). Separation of androstenedione from other steroids was achieved by passage through mini "celite" columns essentially according to Thorneycroft et al. (29) . The stationary phase used was propylene glycol and water (95:5, vol/vol) rather than pure propylene glycol, and androstenedione was eluted with 3.5 ml 15% benzene in isooctane.
Effect ofcastration on plasma estrogen levels after PVL In preliminary experiments, it was demonstrated that plasma levels ofeach hormone achieved a steady plateau after 150-180 min (Fig. 1) . In studies of MCR, three arterial blood samples were collected at 165, 180, and 195 min. After extraction and separation of plasma steroids by TLC (see below), the plasma concentrations of radiolabeled hormones were determined by liquid scintillation spectrometry. MCR was calculated from the mean of plasma hormone concentrations at the three steady state time points according to the following relationship (30) : MCR (ml/min) = infusion rate (mol/min)/plasma concentration at steady state (mol/ml).
In experiments that examined the effect ofbile fistulas on MCR of sex steroids, bile was collected into tared containers at 5-min intervals for 30 min and at 30-min intervals thereafter up to 180 min. The volume of bile was determined by weight, assuming a specific gravity of 1.
Separation ofplasma and biliary steroids
Steroid standards were obtained as follows: androstenedione, testosterone, estrone, estradiol, estriol, DHT, 5a-androstane-3a, 17j-diol (Sa-ADiol), 5,B-androstane-3a, 17#diol (503-ADiol), 6#-hydroxyandrostenedione (6j3OH-AD), 1 l,-hydroxyandrostenedione (1 1j3OH-AD), 16a-hydroxyandrostenedione (16aOH-AD) (all from Sigma Chemical Co.); lla-hydroxyandrostenedione (llaOH-AD) (Steraloids Inc., Wilton, NH); 19-hydroxyandrostenedione (19OH-AD) (Syntex Inc., Palo Alto, CA); 7a-hydroxyandrostenedione (7aOH-AD), 6a-hydroxyandrostenedione (6aOH-AD), 15a-hydroxyandrostenedione (I 5aOH-AD), 14a-hydroxyandrostenedione (I 4aOH-AD), 2a-hydroxyandrostenedione (2aOH-AD) (all provided by Professor D. N. Kirk, Medical Research Council Steroid Reference Collection, Queen Mary's College, University of London, London, UK).
TLC was used to separate estrogens and androgens in samples of plasma or bile (31) . Except in experiments designed to determine MCRs, steroid conjugates were first hydrolyzed by incubating an aliquot (usually 50 ul) of plasma or bile with a buffered solution of fl-glucuronidase/sulfatase (from Helix pomatia type H-l; Sigma Chemical Co.) (10 mg/ml, in 0.2 M acetate, pH 5.0) in a total volume of 1 ml. The incubation was for 3 h at 37°C in a shaking water bath. After hydrolysis, samples were extracted with 3 ml ethylacetate for 15 min. A 0.5-ml aliquot ofthe organic phase was placed in a scintillation vial, 10 ml of Aquasol (New England Nuclear, or DuPont Co., Wil- Diversion ofbile via a biliary fistula did not appear to effect MCR of estradiol in the 3-h infusion experiment (data not shown). The bile duct fistula rats and their sham-operated controls were therefore considered together in the comparison between PVL and control rats. There was no significant difference in MCR of estradiol between PVL rats and controls whether expressed in absolute terms (milliliters per minute) or per gram of liver (Table III) .
MCR ofandrostenedione
During infusion of [3H]androstenedione, plasma levels of [3H]androstenedione reached a plateau after 150 min (Fig. 1) . Separation of unmetabolized androstenedione from other steroids by TLC allowed determination of the MCR of androstenedione. This was similar in PVL and control rats when expressed in absolute terms (milliliters per minute) or per unit mass of liver (Table III) . Biliary diversion did not appear to alter the MCR of androstenedione in either PVL or control rats (data not shown).
Metabolicfate ofinfused [3H]androstenedione
There was extensive metabolism of the infused androstenedione during the 180-min experiment. The profile of resultant 3H-labeled steroids present in plasma at 180 min is illustrated in Fig. 2 . There was a higher proportion of total hydroxylated androstenedione metabolites in plasma from PVL rats as compared with controls (P < 0.001, Fig. 2 ). However, this change was not uniform among the individual metabolites. In Results
Changes in plasma sex steroids in PVL male rats and the effects ofcastration Six wk after PVL, there was an 85% decrease in serum testosterone concentration and a twofold increase in serum estradiol concentration while serum estrone levels were also increased (Table I ). In contrast, there was no change in serum androstenedione levels (Table I ). Castration performed after PVL had no effect on levels of estrone and estradiol after portal bypass (Table II) .
MCR ofestradiol
During constant infusion of [3H]estradiol, plateau levels of radioactivity were achieved by 120 min (Fig. 1) . After extrac- Because accumulation of steroid metabolites in plasma could reflect enhanced production and/or decreased elimination, the excretion of 3H-steroids in bile was also determined during [3H]androstenedione infusion. The metabolic changes suggested by the plasma data were attested for by the bile data. Whereas estradiol formed from infused androstenedione represented < 3% of the total radioactivity in bile from normal rats, it was the major biliary steroid in PVL rats accounting for 25-46% of excreted radioactivity during 180 min (Fig. 3) . In contrast, estrone excretion appeared unaltered. The proportion of radioactivity excreted in bile as estriol was significantly less in PVL rats at almost every time point; however, the area under the curve of estriol excretion against time failed to reach statistical significance (Fig. 3, Table IV ).
There were also distinct differences in the amounts ofindividual androstenedione hydroxylated metabolites excreted in bile during constant infusion of [3H]androstenedione. The excretion of 7aOH-AD was unchanged but that of 16aOH-AD (P < 0.02), 6i3OH-AD (NS), and material that co-chromatographed with 5,B-ADiol (P < 0.05) appeared to be reduced. In contrast, material that co-migrated with the Sa-ADiol metabolite was excreted in significantly greater amounts of PVL rats as compared with controls (Fig. 3, Table IV ). Finally, testosterone and DHT formation appeared to be increased in PVL rats, as indicated by biliary excretion. PVL rats, the proportions of 11,OH-AD and material that co-migrated with 5a-ADiol were significantly increased in plasma compared with controls, whereas no increase was observed in the formation of 6,B0H-AD, 16aOH-AD, and material that co-migrated with 5,B-ADiol. Whereas plasma androstenedione and testosterone levels appeared to be lower in PVL rats during infusion of [3H]-androstenedione, there was a sevenfold greater conversion to estradiol so that this steroid accounted for 15% of the plasma radiolabel in PVL rats (Fig. 2) . Rather surprisingly, there was no increase in the proportion of plasma estrone or estriol derived from infused androstenedione in PVL rats. Levels of DHT were also increased in PVL rats, but this represented < 3% of total plasma radioactivity.
These studies in the intact PVL male rat show that striking and hitherto unsuspected changes in the metabolism of androstenedione most likely account for increased estradiol production after portal bypass. The present findings are also inconsistent with several alternative sources of raised serum estrogens.
A major site of estrogen secretion in the male rat is testicular tissue. It is thus of interest that important changes in the hypothalamic-pituitary-gonadal axis occur after portal bypass (1 1, 17). However, in the present study it was demonstrated that castration of PVL male rats did not lower the elevated serum estrogen levels that were observed. This finding excluded the possibility that the testes were the source of enhanced estrogen production in male rats after portal bypass.
It also seemed possible that serum estrogen concentrations may be raised as the consequence of impaired hepatic clearance of estrone and estradiol. It is well-established that the liver is an important site for removal of estradiol from blood (34, 35) . Since the hepatic extraction of estradiol is avid, it might be anticipated that a reduction in total hepatic blood flow, such as occurs with portal bypass, would result in decreased hepatic clearance of estradiol (34) (35) (36) (37) . Moreover, it seems likely that estradiol undergoes an enterohepatic circula- None of the differences between control and PVL groups are significant (P > 0.05). Values are given as mean±SD. n, the number of animals studied. Another mechanistic explanation for the raised estrogen levels observed in chronic liver disease with portal bypass is that weak androgens accumulate and act as the substrate for "peripheral" aromatization to estrogens (16, 17) . The term peripheral conversion is used with reference to a site external to an endocrine organ, but the precise location of aromatase activity is unclear (20) (21) (22) (23) (24) . It has been reported that serum androstenedione levels are increased in men with chronic liver disease (15, 25) , and it had been assumed that a similar phenomenon occurs in rats as the consequence of portal bypass (13, 16, 17) . The present findings are not consistent with this mechanism because serum androstenedione levels were not elevated in the PVL male rat. Also, there was no impairment of the MCR of androstenedione. Hence, production rates of androstenedione must also be normal in this rat model of portal bypass.
A qualitative difference in androstenedione metabolism in the PVL male rat was indicated by the increased proportion of hydroxylated androstenedione metabolites that accumulated in plasma during androstenedione infusion. Furthermore, there were major differences in the individual pathways of androstenedione hydroxylation. As reflected by the biliary profiles of hydroxylated androstenedione metabolites, the 1 6a-and 6f3-hydroxylation pathways were reduced by 50-70% whereas the 7a-hydroxylation pathway was unaltered. In the liver, the stereospecific hydroxylation of androstenedione is catalyzed by separate forms of P-450 (32, (38) (39) (40) (41) . Thus, the 7a-hydroxylation of androstenedione is catalyzed exclusively by P-450 form a (in the nomenclature of Levin et al. [30] ; this P-450 is termed UT-F by Guengerich et al. [41] ). Androstenedione 1 6a-hydroxylation is catalyzed in untreated rat liver by the male-specific form h (42, 43), also termed P-45OUT-A (40, 41) , and the 6fl-hydroxylase pathway is attributable either to P-450 form g (42) or to the principal pregnenolone 16a-carbonitrile-inducible form, P-450pcN/E (41) . It is now known that P-450PCN/E is also sexually differentiated (male specific) in untreated rat hepatic microsomes. Forms UT-A and PCN/E are both active in the N-demethylation of ethylmorphine (41, 42) . Hence, the present finding that both the 16a-and 6#-steroid hydroxylation pathways are decreased in the PVL male rat are consistent with our earlier observation that microsomal ethylmorphine N-demethylase activity is decreased after portal bypass (4, 1 1).
We have recently demonstrated that levels of form UT-A are extremely low in hepatic microsomes from male rats with experimental cirrhosis (44) . A common characteristic feature of cirrhosis is portal hypertension and portal bypass, and the findings ofthe present study raise the intriguing possibility that major changes in drug and steroid metabolism in cirrhosis (at least in rats) may be due to altered regulation of particular forms of P-450 as the consequence of portal bypass.
It is apparent from the observations that plasma estradiol levels are raised and metabolic clearance of estradiol is normal that the production rate of estradiol must be increased after portal bypass in male rats. With regard to the source of raised serum estrogens in portal bypass, the most important observation of the present study is that there is a 7-to 15-fold increase in conversion of androstenedione to estradiol in the PVL male rat. Ifbiliary excretion of metabolites can be taken as a reliable criterion (and the plasma profile was qualitatively similar), A surprising observation in relation to the increased estradiol production from androstenedione in PVL rats was that there was no increase in estrone production. Estrone is usually the major product of steroid A ring aromatization of androstenedione (15, 16, 18-20, 24, 25, 30) . Greatly increased estradiol production might have occurred because the 1 7(#-oxidoreductase pathway that converts estrone to estradiol is more active after PVL or because testosterone (which was formed from androstenedione in greater amounts in PVL rats as compared with controls) served as the preferred substrate for aromatase (aromatization of testosterone results in estradiol) (15, 16, 20, 24, 25, 30) . However, a third possibility, which is consistent with the present data, is that estriol formation (from androstenedione) is actually reduced in PVL male rats. The third hydroxyl substituent of estriol is in the 16a-position of the steroid nucleus and therefore the question arises as to whether the male-specific 16a-hydroxylase P-45OUT-A is active in the conversion of estradiol to estriol. Certainly androstenedione 16a-hydroxylase activity is greatly diminished after portal bypass and it would appear consistent that impaired activity of this enzyme may well result in raised serum levels of estradiol after portal bypass.
The increased formation of estradiol from androstenedione, which was observed in the intact animal, leads us to conclude that altered hepatic metabolism of androstenedione accounts for the increased estradiol production associated with portal bypass. Accumulation 
